High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from...
Read moreOxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from...
Read moreGLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over...
Read moreMGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away...
Read moreYOOMA Wellness saw revenues decline in its third quarter but managed to taper losses as it continued to buy up...
Read moreINTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter. The...
Read more4C LABS has become the first and only company to be awarded a medical cannabis cultivation licence in Guernsey marking...
Read moreIRELAND now has its first patient through the state-approved Medical Cannabis Access Programme (MCAP) some four years after it was...
Read moreSTENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards...
Read moreCURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in...
Read moreCHILL Brands Group, a retailer of CBD products in the US, UK and Europe, has seen some £180m wiped off...
Read more© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.